"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,2,"Biochemical remission according to normalisation of IGF-1 and GH",NA,"SUBGROUP_AND_OVERALL","Colao 2009",2009,0,0.363906496116438,0,0,16,41,0,0,11,40,0,0.132427937915743,56.564012,1.419069,0.754179,2.670131,"Measured at 48 weeks after the intervention","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
1,2,"Biochemical remission according to normalisation of IGF-1 and GH",NA,"SUBGROUP_AND_OVERALL","Fahlbusch 2017",2017,0,0,0,0,13,26,0,0,1,15,0,0,12.106993,7.5,1.0863,51.781285,"Measured at 12 weeks after the intervention","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
1,2,"Biochemical remission according to normalisation of IGF-1 and GH",NA,"SUBGROUP_AND_OVERALL","Karaca 2011",2011,0,0,0,0,7,11,0,0,3,11,0,0,31.328995,2.333333,0.805653,6.757802,"Measured at 1 year after the intervention","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
2,2,"Adverse events",NA,"SUBGROUP_AND_OVERALL","Cannavo 2001",2001,0,0,0,0,10,10,0,0,6,10,0,0,35.24037,1.615385,0.971652,2.685598,"It was not reported whether the adverse events were transient or persistent","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
2,2,"Adverse events",NA,"SUBGROUP_AND_OVERALL","Fougner 2014",2014,0,0.517437856639685,0,0,6,30,0,0,8,31,0,0.267741935483871,18.856092,0.775,0.305195,1.968003,"There were 2 transient and 4 persistent adverse events in the surgery arm; there were  4 transient and 4 persistent in the preoperative pharmalogical therapy and surgey arm","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
2,2,"Adverse events",NA,"SUBGROUP_AND_OVERALL","Li 2012",2012,0,0.511067976095623,0,0,7,25,0,0,7,24,0,0.261190476190476,20.155907,0.96,0.396068,2.326874,"There were 5 transient and 2 persistent adverse events in the surgery arm; there were 5 transient and 2 persistent in the preoperative pharmalogical therapy and surgey arm","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
2,2,"Adverse events",NA,"SUBGROUP_AND_OVERALL","Mao 2010",2010,0,0.570833022990134,0,0,5,49,0,0,7,49,0,0.325850340136054,15.425512,0.714286,0.243258,2.097381,"There were 5 transient and 0 persistent adverse events in the surgery arm; there were 7 transient and 0 persistent in the preoperative pharmalogical therapy and surgey arm","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
2,2,"Adverse events",NA,"SUBGROUP_AND_OVERALL","Shen 2010",2010,0,0.716583605374881,0,0,9,20,0,0,2,19,0,0.513492063492063,10.322118,4.275,1.056729,17.294531,"There were 9 transient and 0 persistent adverse events in the surgery arm; there were 2 transient and 0 persistent in the preoperative pharmalogical therapy and surgey arm","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013561.pub2/full","10.1002/14651858.CD013561.pub2","2::overall","CD013561_pub2_data","significance_only",TRUE,FALSE,TRUE,0.713938130484974,0.170451732383516,-0.0562942409637575,1.4841705019337,0.0194693245748715,0.32143414019216,FALSE,FALSE
